Adhesion molecule expression and regulation on cells of the central nervous system

Journal of Neuroimmunology

Volumn 98, Issue 2, 1999, Pages 77-88

  Lee, Sung Joong ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adhesion molecule; Central nervous system; Multiple sclerosis

Indexed keywords

ANTIBODY; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ASTROCYTE; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; GLIA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032981648     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00084-3     Document Type: Article

References (114)

1. Adamson P., Etienne S., Couraud P.-O., Calder V., Greenwood J. Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway. J. Immunol. 162:1999;2964-2973.
2. Aloisi F., Borsellino G., Samoggia P., Testa U., Chelucci C., Russo G., Peschle C., Levi G. Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J. Neurosci. Res. 32:1992;494-506.
3. Aloisi F., Ria F., Penna G., Adorini L. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J. Immunol. 160:1998;4671-4680.
4. Archelos J.J., Jung S., Mäurer M., Schmied M., Lassmann H., Tamatani T., Miyasaka M., Toyka K.V., Hartung H.-P. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 34:1993;145-154.
5. Arsura M., Wu M., Sonenshein G.E. TGFβ1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: transcriptional activation of IκBα Immunity. 5:1996;31-40.
6. Ballestas M.E., Benveniste E.N. Interleukin-1β and tumor necrosis factor-α mediated regulation of ICAM-1 gene expression in astrocytes requires protein kinase C activity. GLIA. 14:1995;267-278.
7. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Jr. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
8. Barten D.M., Ruddle N.H. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 51:1994;123-133.
9. Becker J.C., Dummer R., Hartmann A.A., Burg G., Schmidt R.E. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α J. Immunol. 147:1991;4398-4401.
10. Becker J.C., Termeer C., Schmidt R.E., Bröcker E.-B. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J. Immunol. 151:1993;7224-7232.
11. Berlin C., Berg E.L., Briskin M.J., Andrew D.P., Kilshaw P.J., Holzmann B., Weissman I.L., Hamann A., Butcher E.C. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell. 74:1993;185-195.
12. Bö L., Peterson J.W., Mork S., Hoffman P.A., Gallatin W.M., Ransohoff R.M., Trapp B.D. Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the β2 integrin LFA-1 in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55:1996;1060-1072.
13. Brosnan C.F., Cannella B., Battistini L., Raine C.S. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology. 45:1995;S16-S21.
14. Calabresi P.A., Pelfrey C.M., Tranquill L.R., Maloni H., McFarland H.F. VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta. Neurology. 49:1997;1111-1116.
15. Calabresi P.A., Stone L.A., Bash C.N., Frank J.A., McFarland H.F. Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI. Neurology. 48:1997;1446-1448.
16. Calabresi P.A., Tranquill L.R., Dambrosia J.M., Stone L.A., Maloni H., Bash C.N., Frank J.A., McFarland H.F. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β-1b. Ann. Neurol. 41:1997;669-674.
17. Caldenhoven E., Coffer P., Yuan J., Van De Stolpe A., Horn F., Kruijer W., Van Der Saag P.T. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-γ involves binding of distinct factors to a palindromic response element. J. Biol. Chem. 269:1994;21146-21154.
18. Cannella B., Raine C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:1995;424-435.
19. Carson M.J., Reiley C.R., Sutcliffe J.G., Lo D. Mature microglia resemble immature antigen-presenting cells. GLIA. 22:1998;72-85.
20. Chirathaworn C., Tibbetts S.A., Chan M.A., Benedict S.H. Cross-inking of ICAM-1 on T cells induces transient tyrosine phosphorylation and inactivation of cdc2 kinase. J. Immunol. 155:1995;5479-5482.
21. Clayton A., Evans R.A., Pettit E., Hallett M., Williams J.D., Steadman R. Cellular activation through the ligation of intercellular adhesion molecule-1. J. Cell Sci. 111:1998;443-453.
22. + T lymphocytes. Proc. Natl. Acad. Sci. USA. 88:1991;6403-6407.
23. + T lymphocytes. J. Immunol. 148:1992;1985-1992.
24. + T lymphocytes. J. Immunol. 151:1993;2368-2379.
25. Diamond M.S., Staunton D.E., Marlin S.D., Springer T.A. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell. 65:1991;961-971.
26. Dopp J.M., Breneman S.M., Olschowka J.A. Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis. J. Neuroimmunol. 54:1994;129-144.
27. Dore-Duffy P., Newman W., Balabanov R., Lisak R.P., Mainolfi E., Rothlein R., Peterson M. Circulating soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann. Neurol. 37:1995;55-62.
28. Droogan A.G., McMillan S.A., Douglas J.P., Hawkins S.A. Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1. J. Neuroimmunol. 64:1996;185-191.
29. Durieu-Trautmann O., Chaverot N., Cazaubon S., Strosberg A.D., Couraud P.-O. Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J. Biol. Chem. 269:1994;12536-12540.
30. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:1990;577-584.
31. Engelhardt B., Vestweber D., Hallmann R., Schulz M. E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood. 90:1997;4459-4472.
32. Engelhardt B., Laschinger M., Schulz M., Samulowitz U., Vestweber D., Hoch G. The development of experimental autoimmune encephalomyelitis in the mouse requires α4-integrin but not α4β7-integrin. J. Clin. Invest. 102:1998;2096-2105.
33. Etienne S., Adamson P., Greenwood J., Strosberg A.D., Cazaubon S., Couraud P.-O. ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J. Immunol. 161:1998;5755-5761.
34. Ford A.L., Foulcher E., Lemckert F.A., Sedgwick J.D. Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 184:1996;1737-1745.
35. Foster C.A. VCAM-1/α4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders. J. Allergy Clin. Immunol. 98:1996;S270-S277.
36. Frohman E.M., Frohman T.C., Dustin M.L., Vayuvegula B., Choi B., Gupta A., van den Noort S., Gupta S. The induction of intercellular adhesion molecule1 (ICAM-1) expression on human fetal astrocytes by interferon-γ, tumor necrosis factor-α, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation. J. Neuroimmunol. 23:1989;117-124.
37. Geissler D., Gaggl S., Möst J., Greil R., Herold M., Dierich M. A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM-1) modulates the release of tumor necrosis factor-α, interferon-γ and interleukin 1. Eur. J. Immunol. 20:1990;2591-2596.
38. Giovannoni G., Thorpe J.W., Kidd D., Kendall B.E., Moseley I.F., Thompson A.J., Keir G., Miller D.H., Feldmann M., Thompson E.J. Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease. J. Neurol. Neurosurg. Psychiatry. 60:1996;20-26.
39. Giovannoni G., Lai M., Thorpe J., Kidd D., Chamoun V., Thompson A.J., Miller D.H., Feldmann M., Thompson E.J. Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging. Neurology. 48:1997;1557-1565.
40. Greenwood J., Wang Y., Calder V.L. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. Immunology. 86:1995;408-415.
41. Hahne M., Lenter M., Jäger U., Vestweber D. A novel soluble form of mouse VCAM-1 is generated from a glycolipid-anchored splicing variant. Eur. J. Immunol. 24:1994;421-428.
42. Hartung H.-P., Michels M., Reiners K., Seeldrayers P., Archelos J.J., Toyka K.V. Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis. Neurology. 43:1993;2331-2335.
43. Hartung H.-P., Reiners K., Archelos J.J., Michels M., Seeldrayers P., Heidenreich F., Pflughaupt K.W., Toyka K.V. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann. Neurol. 38:1995;186-193.
44. Hemmerich S., Leffler H., Rosen S.D. Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin. J. Biol. Chem. 270:1995;12035-12047.
45. Héry C., Sébire G., Peudenier S., Tardieu M. Adhesion to human neurons and astrocytes of monocytes: the role of interaction of CR3 and ICAM-1 and modulation by cytokines. J. Neuroimmunol. 57:1995;101-109.
46. Holland J., Owens T. Signaling through intercellular adhesion molecule 1 (ICAM-1) in a B cell lymphoma line. The activation of lyn tyrosine kinase and the mitogen-activated protein kinase pathway. J. Biol. Chem. 272:1997;9108-9112.
47. Hurwitz A.A., Lyman W.D., Guida M.P., Calderon T.M., Berman J.W. Tumor necrosis factor α induces adhesion molecule expression on human fetal astrocytes. J. Exp. Med. 176:1992;1631-1636.
48. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
49. Johnston G.I., Cook R.G., McEver R.P. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell. 56:1989;1033-1044.
50. Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood. 88:1996;3259-3287.
51. Kerr L.D., Miller D.B., Matrisian L.M. TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell. 61:1990;267-278.
52. Koyama Y., Tanaka Y., Saito K., Abe M., Nakatsuka K., Morimoto I., Auron P.E., Eto S. Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1β transcription. J. Immunol. 157:1996;5097-5103.
53. Kraus J., Oschmann P., Engelhardt B., Schiel C., Hornig C., Bauer R., Kern A., Traupe H., Dorndorf W. Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosis. Acta Neurol. Scand. 98:1998;102-109.
54. Kuchroo V.K., Martin C.A., Greer J.M., Ju S.-T., Sobel R.A., Dorf M.E. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:1993;4371-4382.
55. Lawson C., Ainsworth M., Yacoub M., Rose M. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-κB-independent mechanism. J. Immunol. 162:1999;2990-2996.
56. Leca G., Mansur S.E., Bensussan A. Expression of VCAM-1 (CD106) by a subset of TCRγδ-bearing lymphocyte clones. J. Immunol. 154:1995;1069-1077.
57. Lee S.J., Hou J., Benveniste E.N. Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-κB and C/EBP isoforms. J. Neuroimmunol. 92:1998;196-207.
58. Ley K., Bullard D.C., Arbones M.L., Bosse R., Vestweber D., Tedder T.F., Beaudet A.L. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J. Exp. Med. 181:1995;669-675.
59. 2) on human neutrophils. J. Exp. Med. 173:1991;1493-1500.
60. Lorenzon P., Vecile E., Nardon E., Ferrero E., Harlan J.M., Tedesco F., Dobrina A. Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. J. Cell Biol. 142:1998;1381-1391.
61. Lyons P.D., Benveniste E.N. Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease. GLIA. 22:1998;103-112.
62. Male D., Rahman J., Pryce G., Tamatani T., Miyasaka M. Lymphocyte migration into the CNS modelled in vitro: roles of LFA-1, ICAM-1, and VLA-4. Immunology. 81:1994;366-372.
63. Matsumoto Y., Ohmori K., Fujiwara M. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology. 76:1992;209-216.
64. McDonnell G.V., McMillan S.A., Douglas J.P., Droogan A.G., Hawkins S.A. Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis. J. Neuroimmunol. 85:1998;186-192.
65. Modur V., Li Y., Zimmerman G.A., Prescott S.M., McIntyre T.M. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J. Clin. Invest. 100:1997;2752-2756.
66. Moingeon P., Chang H.C., Wallner B.P., Stebbins C., Frey A.Z., Reinherz E.L. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature. 339:1989;312-314.
67. Myers C.L., Wertheimer S.J., Schembri-King J., Parks T., Wallace R.W. Induction of ICAM-1 by TNF-α, IL-1β, and LPS in human endothelial cells after downregulation of PKC. Am. J. Physiol. Cell Physiol. 32:1992;C767-C772.
68. Nikcevich K.M., Gordon K.B., Tan L., Hurst S.D., Kroepfl J.F., Gardinier M., Barrett T.A., Miller S.D. INF-γ-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 158:1997;614-621.
69. Oh J.-W., Van Wagoner N., Ros-John S., Benveniste E.N. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 expression. J. Immunol. 161:1998;4992-4999.
70. Pigott R., Dillon L.P., Hemingway I.H., Gearing A.J.H. Soluble forms of e-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultures endothelial cells. Biochem. Biophys. Res. Commun. 187:1992;584-589.
71. Poudrier J., Owens T. CD54/intercellular adhesion molecule 1 and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation. J. Exp. Med. 179:1994;1417-1427.
72. Raine C.S. The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 36:1994;S61-72.
73. Raine C.S., Cannella B. Adhesion molecules and central nervous system inflammation. Semin. Neurosci. 4:1992;201-211.
74. 2+ mobilization. Eur. J. Immunol. 27:1997;1530-1538.
75. Rieckmann P., Martin S., Weichselbraun I., Albrecht M., Kitze B., Weber T., Tumani H., Broocks A., Lüer W., Helwig A., Poser S. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis. Neurology. 44:1994;2367-2372.
76. Rieckmann P., Michel U., Albrecht M., Bruck W., Wockel L., Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J. Neuroimmunol. 60:1995;9-15.
77. Rieckmann P., Michel U., Albrecht M., Brück W., Wöckel L., Felgenhauer K. Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system. Neurosci. Lett. 186:1995;61-64.
78. Rieckmann P., Altenhofen B., Riegel A., Baudewig J., Felgenhauer K. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis. Ann. Neurol. 41:1997;326-333.
79. Roep B.O., Heidenthal E., de Vries R.R.P., Kolb H., Martin S. Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet. 343:1994;1590-1593.
80. Rosenman S.J., Shrikant P., Dubb L., Benveniste E.N., Ransohoff R.M. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154:1995;1888-1899.
81. Rothlein R., Mainolfi E.A., Czajkowski M., Marlin S.D. A form of circulating ICAM-1 in human serum. J. Immunol. 147:1991;3788-3793.
82. Rothlein R., Kishimoto T.K., Mainolfi E. Cross-linking of ICAM-1 induces co-signaling of an oxidative burst from mononuclear leukocytes. J. Immunol. 152:1994;2488-2495.
83. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
84. Sako D., Chang X.J., Barone K.M., Vachino G., White H.M., Shaw G., Veldman G.M., Bean K.M., Ahern T.J., Furie B.et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 75:1993;1179-1186.
85. Sanchez-Madrid F., Nagy J.A., Robbins E., Simon P., Springer T.A. A human leukocyte differentiation antigen family with distinct α-subunits and a common β-subunit. J. Exp. Med. 158:1983;1785-1803.
86. Sano H., Nakagawa N., Chiba R., Kurasawa K., Saito Y., Iwamoto I. Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 250:1998;694-698.
87. Selmaj K., Walczak A., Mycko M., Berkowicz T., Kohno T., Raine C.S. Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down-regulation of VCAM-1/VLA-4. Eur. J. Immunol. 28:1998;2035-2044.
88. Seth R., Raymond F.D., Makgoba M.W. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet. 338:1991;83-84.
89. Sharief M.K., Noori M.A., Ciardi M., Cirelli A., Thompson E.J. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage. J. Neuroimmunol. 43:1993;15-22.
90. Shrikant P., Benveniste E.N. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J. Immunol. 157:1996;1819-1822.
91. Shrikant P., Chung I.Y., Ballestas M., Benveniste E.N. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytes. J. Immunol. 51:1994;209-220.
92. Shrikant P., Weber E., Jilling T., Benveniste E.N. ICAM-1 gene expression by glial cells: differential mechanisms of inhibition by interleukin-10 and interleukin-6. J. Immunol. 155:1995;1489-1501.
93. Shrikant P., Benos D.J., Tang L.-P., Benveniste E.N. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells: Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J. Immunol. 156:1996;1307-1314.
94. Shrikant P., Lee S.J., Kalvakalanu I., Ransohoff R.M., Benveniste E.N. Stimulus-specific inhibition of ICAM-1 gene expression by TGF-β J. Immunol. 157:1996;892-900.
95. Sligh J.E. Jr., Ballantyne C.M., Rich S.S., Hawkins H.K., Smith C.W., Bradley A., Beaudet A.L. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 90:1993;8529-8533.
96. Smith C.W., Kishimoto T.K., Abbassi O., Hughes B., Rothlein R., McIntire L.V., Butcher E., Anderson D.C., Abbass O. Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J. Clin. Invest. 87:1991;609-618. [published erratum appears in J. Clin. Invest. 1991. 87 (5), 1873].
97. Sobel R.A., Mitchell M.E., Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 136:1990;1309-1316.
98. Soilu-Hänninen M., Röyttä M., Salmi A., Salonen R. Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis. J. Neuroimmunol. 72:1997;95-105.
99. Soos J.M., Morrow J., Ashley T.A., Szente B.E., Bikoff E.K., Zamvil S.S. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J. Immunol. 161:1998;5959-5966.
100. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell. 76:1994;301-314.
101. Staunton D.E., Marlin S.D., Stratowa C., Dustin M.L., Springer T.A. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell. 52:1988;925-933.
102. Steegmaier M., Levinovitz A., Isenmann S., Borges E., Lenter M., Kocher H.P., Kleuser B., Vestweber D. The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature. 373:1995;615-620.
103. Steffen B.J., Butcher E.C., Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/j mouse. Am. J. Pathol. 145:1994;189-201.
104. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
105. Tan L., Gordon K.B., Mueller J.P., Matis L.A., Miller S.D. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-γ-activated SJL/J astrocytes. J. Immunol. 160:1998;4271-4279.
106. Trojano M., Avolio C., Ruggieri M., Defazio G., Giuliani F., Paolicelli D., Livrea P. Antiinflammatory effects of rIFNβ-1b in multiple sclerosis (MS): longitudinal changes of the serum soluble intercellular adhesion molecule-1 (sICAM-1), TNFα and T-cell subsets. Neurology. 48:1997;A244.
107. Trojano M., Avolio C., Ruggieri M., De Robertis F., Giuliani F., Paolicelli D., Livrea P. Soluble intercellular adhesion molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system. Multiple Sclerosis. 4:1998;39-44.
108. Tsukada N., Matsuda M., Miyagi K., Yanagisawa N. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology. 43:1993;2679-2682.
109. Van Seventer G.A., Shimizu Y., Horgan K.J., Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:1990;4579-4586.
110. Washington R., Burton J., Todd R.F. III, Newman W., Dragovic L., Dore-Duffy P. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann. Neurol. 35:1994;89-97.
111. Welsh C.T., Rose J.W., Hill K.E., Townsend J.J. Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1α J. Neuroimmunol. 43:1993;161-168.
112. Winkler M., Benveniste E.N. Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes. GLIA. 22:1998;171-179.
113. Ybarrondo B., O'Rourke A.M., Brian A.A., Mescher M.F. Contribution of lymphocyte function-associated-1/intercellular adhesion molecule-1 binding to the adhesion/signaling cascade of cytotoxic T lymphocyte activation. J. Exp. Med. 179:1994;359-363.
114. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature. 356:1992;63-66.